phase readout
saveNCT05876312: Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: ADARx Pharmaceuticals, Inc.. Phase: PHASE1. Conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH)
view source ↗
comments(0)
5-min edit window · permanent after that